KPIs & Operating Metrics(New)
Animal Health Revenue BreakdownBreakdown Of AssetsEmployee StatisticsGross Margin %Gross ProfitGross Profit AnnualGross Profit Annual %InventoriesLong Lived Assets By RegionNon Gaap ProfitabilityNon Gaap Profitability %Non Gaap Profitability AnnualNon Gaap Profitability Annual %Operating Expense SegregationOpex As A % Of Total Revenue %Pharmaceuticals Revenue BreakdownPharmaceuticals Revenue Breakdown AnnualPrice Change By Region %Price Change By Region Annual %Price, Volume & Rate Change Total %Property And Equipment SegregationRate Change By Region %Rate Change By Region Annual %Revenue By Business VerticalRevenue By Business Vertical %Revenue By Business Vertical AnnualRevenue By Business Vertical Annual %Revenue By Customer LocationRevenue By Customer Location %Revenue By Customer Location AnnualRevenue By Customer Location Annual %Revenue By RegionRevenue By Region AnnualRevenue By Region Annual %Revenue By SegmentRevenue By Segment %Volume Change By Region %Volume Change By Region Annual %
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Eli Lilly (LLY) Gross Profit (2016 - 2025)

Historic Gross Profit for Eli Lilly (LLY) over the last 17 years, with Q4 2025 value amounting to $15.9 billion.

  • Eli Lilly's Gross Profit rose 4304.47% to $15.9 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $54.1 billion, marking a year-over-year increase of 4778.7%. This contributed to the annual value of $54.1 billion for FY2025, which is 4778.7% up from last year.
  • Per Eli Lilly's latest filing, its Gross Profit stood at $15.9 billion for Q4 2025, which was up 4304.47% from $14.6 billion recorded in Q3 2025.
  • In the past 5 years, Eli Lilly's Gross Profit ranged from a high of $15.9 billion in Q4 2025 and a low of $4.8 billion during Q2 2021
  • For the 5-year period, Eli Lilly's Gross Profit averaged around $8.0 billion, with its median value being $6.8 billion (2023).
  • Per our database at Business Quant, Eli Lilly's Gross Profit crashed by 705.14% in 2023 and then skyrocketed by 5744.53% in 2025.
  • Quarter analysis of 5 years shows Eli Lilly's Gross Profit stood at $5.9 billion in 2021, then dropped by 3.29% to $5.8 billion in 2022, then surged by 31.49% to $7.6 billion in 2023, then soared by 47.11% to $11.1 billion in 2024, then surged by 43.04% to $15.9 billion in 2025.
  • Its Gross Profit was $15.9 billion in Q4 2025, compared to $14.6 billion in Q3 2025 and $13.1 billion in Q2 2025.